Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05161169 · ClinicalTrials.gov registry record · NA
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT05161169 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 500 participants.
The verdict
NCT05161169, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
This research study is exploring the use of genomic sequencing in the newborn period to screen healthy babies for current and future health risks. The study will enroll a diverse cohort of 500 healthy infants and their parents from Boston, MA; New York City, NY; and Birmingham, AL. A small blood sample will be collected from each infant, and whole genome sequencing will be performed in 1/2 of the cohort following a randomized controlled trial design. 3 months later, the randomization status and sequencing results will be shared with parents and pediatricians. Investigators will study the medical, behavioral, and economic outcomes of genomic sequencing to better understand how this technology can be implemented in outpatient primary care settings.
Interventions
- GENETIC Genome Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-12-21 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05161169
The ClinicalTrials.gov registry entry for NCT05161169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genome Sequencing is the first listed.
NCT05161169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05161169 about?
NCT05161169 is a clinical study titled "Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants". This research study is exploring the use of genomic sequencing in the newborn period to screen healthy babies for current and future health risks. The study will enroll a diverse cohort of 500 healthy infants and their parents from Boston, MA; New York City, NY; and Birmingham, AL. A small blood sam...
What is the current status of trial NCT05161169?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2022-12-21. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05161169?
The interventions under investigation include: Genome Sequencing (GENETIC).
Who is sponsoring clinical trial NCT05161169?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.